Showing 1 - 20 results of 59 for search '"ОСТРАЯ ДЫХАТЕЛЬНАЯ НЕДОСТАТОЧНОСТЬ"', query time: 0.86s Refine Results
  1. 1
    Academic Journal

    Source: Journal Infectology; Том 17, № 1 (2025); 114-119 ; Журнал инфектологии; Том 17, № 1 (2025); 114-119 ; 2072-6732

    File Description: application/pdf

    Relation: https://journal.niidi.ru/jofin/article/view/1740/1188; Fouka E., Drakopanagiotakis F., Steiropoulos P. Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome // International Journal of Molecular Sciences. 2024. Vol. 72, N 25. P. 240-249. DOI:10.1016/j.matbio.2018.05.004; Pedchenko V., Kitching A. R., Hudson B. G. Goodpasture’s autoimmune disease — A collagen IV disorder // Matrix Biology. 2018. Vol. 71-72, P. 240–249. DOI:10.1016/j.matbio.2018.05.004; Rovin B., Adler S. et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases // Kidney International. 2021. Vol. 4, Т.100. P. 1–276. DOI:10.1016/j.kint.2021.05.015; Reggiani F., L’Imperio V., Calatroni M., Pagni, F. Good-pasture syndrome and anti-glomerular basement membrane disease // Clinical and experimental rheumatology. 2023. Vol. 41, N 5. P. 964–974. https://doi.org/10.55563/clinexprheumatol/tep3k5; Asim M., Akhtar M. Epidemiology, Impact, and Management Strategies of Anti-Glomerular Basement Membrane Disease // International journal of nephrology and renovascular disease. 2022. Vol. 15, P.129–138. DOI:10.2147/IJNRD.S326427; Hellmark T., Segelmark M. Diagnosis and classification of Goodpasture’s disease (anti-GBM) // Journal of Autoimmunity. 2014. Vol. 48–49, P. 108–112. DOI:10.1016/j.jaut.2014.01.024; McAdoo S. P., Pusey C. D. Anti-glomerular basement membrane disease // Clinical Journal of the American Society of Nephrology. 2017. Vol. 7, T. 12. P. 1162–1172. DOI:10.2215/CJN.01380217; Schwartz J. Padmanabhan A. et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue // Journal of Clinical Apheresis. 2016. Vol. 3, Т. 31. P. 149–338. DOI:10.1002/jca.21470; Jain R., Dgheim H., Bomback A. S. Rituximab for Anti-Glomerular Basement Membrane Disease // Kidney international reports. 2018. Vol. 4, Т. 4. P. 614–618. DOI:10.1016/j.ekir.2018.12.002; Matthay M. A., Arabi, Y. et al. A New Global Definition of Acute Respiratory Distress Syndrome // American Journal of Respiratory and Critical Care Medicine. 2024. Vol. 1, Т.4. P. 37–47. DOI:10.1164/rccm.202303-0558WS; Зайцев А.А., Макаревич А.М., Паценко М.Б., Синопальников А.И., Серговенцев А.А., Крюков Е.В. Диагностика и лечение внебольничной пневмонии у военнослужащих (методические указания). Клиническая медицина. 2024;102(3):212-229. https://doi.org/10.30629/0023-2149-2023-101-11-212-229; https://journal.niidi.ru/jofin/article/view/1740

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    Academic Journal

    Source: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 20, № 5 (2023); 61-66 ; Вестник анестезиологии и реаниматологии; Том 20, № 5 (2023); 61-66 ; 2541-8653 ; 2078-5658

    File Description: application/pdf

    Relation: https://www.vair-journal.com/jour/article/view/868/663; Андреенко А. А., Ершов Е. Н., Лахин Р. Е. и др. Оценка профессионального мастерства анестезиологов-реаниматологов // Военно-медицинский журнал. – 2018. – Т. 339, № 12. – С. 9–15.; Андреенко А. А., Макаренко Е. П., Цыганков К. А. и др. Высокореалистичная симуляция при обучении клинических ординаторов действиям в критических ситуациях во время анестезии // Виртуальные технологии в медицине. – 2019. – Т. 21, № 1. – С. 6–8. Doi:10.46594/2687-0037-2019-1-6.; Власенко А. В., Остапченко Д. А., Шестаков Д. А. Эффективность применения маневра «открытия легких» в условиях ИВЛ у больных с острым респираторным дистресс-синдромом // Общая реаниматология. – 2006. –Т. 2, № 4. – С. 50–59.; Гельфанд Б. Р., Кассиль В. Л. Острый респираторный дистресс-синдром. Практическое руководство. – М.: Литтерра, 2007. – 232 с.; Храпов К. Н., Полушин Ю. С., Мешаков Д. П. Особенности острого повреждения легких при тяжелой госпитальной пневмонии // Вестник анестезиологии и реаниматологии. – 2011. – Т. 8, № 5. – С. 23–28.; Цыганков К. А., Грачев И. Н., Шаталов В. И. и др. Влияние неинвазивных методик респираторной поддержки на частоту летального исхода у взрослых пациентов с тяжелой дыхательной недостаточностью, вызванной новой коронавирусной инфекцией // Вестник анестезиологии и реаниматологии. – 2021. – Т. 18, № 1. – С. 47–56. Doi:10.21292/2078-5658-2021-18-1-47-56.; Ярошецкий А. И., Грицан А. И., Авдеев С. Н. Диагностика и интенсивная терапия острого респираторного дистресс-синдрома. Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов» // Анестезиология и реаниматология. – 2020. – № . 2. – С. 5–39. Doi:10.17116/anaesthesiology20200215.; Chiumello D., Brioni M. Severe hypoxemia: which strategy to choose // Critical Care. – 2016. – Т. 20. – № . 1. – Р. 1–9. Doi:10.1186/s13054-016-1304-7.; Duan E. H., Adhikari N. K., Aragon F. et al. Management of acute respiratory distress syndrome and refractory hypoxemia. A multicenter observational study // Annals of the American Thoracic Society. – 2017. – Vol. 14, № 12. – Р. 1818–1826. Doi:10.1513/AnnalsATS.201612-1042OC.; Grimaldi S., Hraiech E., Boutin J. C. et al. Hypoxemia in the ICU: prevalence, treatment, and outcome // Annals of Intensive Care. – 2018. – Vol. 8, № 1. – P. 1–11. Doi:10.1186/s13613-018-0424-4.

  8. 8
    Academic Journal

    Source: FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology; Vol 16, No 1 (2023); 134–143 ; ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология; Vol 16, No 1 (2023); 134–143 ; 2070-4933 ; 2070-4909

    File Description: application/pdf

    Relation: https://www.pharmacoeconomics.ru/jour/article/view/800/464; Федеральная служба в сфере защиты прав потребителей и благополучия человека. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2018 году». URL: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=12053 (дата обращения 28.01.2023).; Федеральная служба в сфере защиты прав потребителей и благополучия человека. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2019 году». URL: https://www.rospotrebnadzor.ru/upload/iblock/8e4/gosdoklad-za-2019_seb_29_05.pdf (дата обращения 28.01.2023).; Федеральная служба в сфере защиты прав потребителей и благополучия человека. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2020 году». URL: https://www.rospotrebnadzor.ru/upload/iblock/5fa/gd-seb_02.06-_s-podpisyu_.pdf (дата обращения 28.01.2023).; Федеральная служба в сфере защиты прав потребителей и благополучия человека. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2021 году». URL: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=21796 (дата обращения 28.01.2023).; Ashbaugh D.G., Bigelow D.B., Petty T.L., Levine B.E. Acute respiratory distress in adults. Lancet. 1967; 2 (7511): 319–23. https://doi.org/10.1016/s0140-6736(67)90168-7.; Bernard G.R., Artigas A., Brigham K.L., et al. Report of the American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med. 1994; 20 (3): 225–32. https://doi.org/10.1007/BF01704707.; Ranieri V.M., Rubenfeld G.D., Thompson B.T., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307 (23): 2526– 33. https://doi.org/10.1001/jama.2012.5669.; Cutts S., Talboys R., Paspula C., et al. Adult respiratory distress syndrome. Ann R Coll Surg Engl. 2017; 99 (1): 12–6. https://doi.org/10.1308/rcsann.2016.0238.; Ярошецкий А.И., Грицан А.И., Авдеев С.Н. и др. Диагностика и интенсивная терапия острого респираторного дистресс-синдрома (Клиническиe рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов»). Анестезиология и реаниматология. 2020; 2: 5–39. https://doi.org/10.17116/anaesthesiology20200215.; Katzenstein A.L., Bloor C.M., Leibow A.A. Diffuse alveolar damage – the role of oxygen, shock, and related factors a review. Am J Pathol. 1976; 85 (1): 209–28.; Katzenstein A.L. Pathogenesis of “fibrosis” in interstitial pneumonia: an electron microscopic study. Hum Pathol. 1985; 16 (10): 1015–24. https://doi.org/10.1016/S0046-8177(85)80279-3.; Suchyta M.R., Clemmer T.P., Elliott C.G., et al. The adult respiratory distress syndrome. A report of survival and modifying factors. Chest. 1992; 101 (4): 1074–9. https://doi.org/10.1378/chest.101.4.1074.; Xu Z., Shi L., Wang Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8 (4): 420–2. https://doi.org/10.1016/S2213-2600(20)30076-X.; Grasselli G., Tonetti T., Protti A., et al. Pathophysiology of COVID19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020; 8 (12): 1201–8. https://doi.org/10.1016/S2213-2600(20)30370-2.; Guo L., Jin Z., Gan T.J., Wang E. Silent hypoxemia in patients with COVID-19 pneumonia: a review. Med Sci Monit. 2021; 27: e930776. https://doi.org/10.12659/MSM.930776.; Пальман А.Д., Андреев Д.А., Сучкова С.А. Тихая гипоксемия у пациентов с тяжелой SARS-CoV-2-пневмонией. Сеченовский вестник. 2020; 11 (2): 87–91. https://doi.org/10.47093/2218-7332.2020.11.2.87-91.; Gattinoni L., Coppola S., Cressoni M., et al. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020; 201 (10): 1299–300. https://doi.org/10.1164/rccm.202003-0817LE.; Fan E., Beitler J.R., Brochard L., et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020; 8 (8): 816–21. https://doi.org/10.1016/S2213-2600(20)30304-0.; Alsharif H., Belkhouja K. 267: Feasibility and efficacy of prone position combined with CPAP in COVID-19 patients with AHRF. Crit Care Med. 2021; 49 (1 Suppl. 1): 120. https://doi.org/10.1097/01.ccm.0000726956.06837.13.; Chicoine J., González M., Meyers A., et al. COVID-19 ventilator management strategies: what we have learned and future management options? Am J Respir Crit Care Med. 2021; 203: A2559. https://doi.org/10.1164/AJRCCM-CONFERENCE.2021.203.1_MEETINGABSTRACTS.A2559.; Бородулина Е.А., Черногаева Г.Ю., Бородулин Б.Е. и др. Оптимизация выбора респираторной поддержки в интенсивной терапии тяжелой внебольничной пневмонии. Клиническая медицина. 2018; 96 (2): 152–7. https://doi.org/10.18821/0023-2149-2018-96-2-152-157.; Yang Y., Peng F., Wang R., et al. The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun. 2020; 109: 102434. https://doi.org/10.1016/j.jaut.2020.102434.; Alhazzani W., Møller M.H., Arabi Y.M., et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020; 46 (5): 854–87. https://doi.org/10.1007/s00134-020-06022-5.; Matthay M.A., Aldrich J.M., Gotts J.E. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med. 2020; 8 (5): 433–4. https://doi.org/10.1016/S2213-2600(20)30127-2.; Candan S.A., Elibol N., Abdullahi A. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19. Physiother Theory Pract. 2020; 36 (6): 663–8. https://doi.org/10.1080/09593985.2020.1766181.; Глыбочко П.В., Фомин В.В., Авдеев С.Н. и др. Клиническая характеристика 1007 больных тяжелой SARS-CoV-2 пневмонией, нуждавшихся в респираторной поддержке. Клиническая фармакология и терапия. 2020; 29 (2): 21–9. https://doi.org/10.32756/0869-5490-2020-2-21-29.; Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323 (20): 2052–9. https://doi.org/10.1001/jama.2020.6775.; Grasselli G., Zangrillo A., Zanella A., et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323 (16): 1574–81. https://doi.org/10.1001/jama.2020.5394.; Матюшков Н.С., Тюрин И.Н., Авдейкин С.Н. и др. Респираторная поддержка у пациентов с COVID-19. Опыт инфекционного стационара в Коммунарке: одноцентровое ретроспективное исследование. Вестник интенсивной терапии им. А.И. Салтанова. 2021 (3): 47–60. https://doi.org/10.21320/1818-474X-2021-3-47-60.; Spinelli E., Mauri T., Beitler J.R., et al. Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions. Intensive Care Med. 2020; 46 (4): 606–18. https://doi.org/10.1007/s00134-020-05942-6.; Lopez A., Lakbar I., Delamarre L., et al. Management of SARS-CoV-2 pneumonia in intensive care unit: an observational retrospective study comparing two bundles. J Crit Care. 2021; 65: 200–4. https://doi.org/10.1016/j.jcrc.2021.06.014.; Attaway A.H., Scheraga R.G., Bhimraj A., et al. Severe COVID-19 pneumonia: pathogenesis and clinical management. BMJ. 2021; 372: n436. https://doi.org/10.1136/bmj.n436.; Ярошецкий А.И., Власенко А.В., Грицан А.И. и др. Применение неинвазивной вентиляции легких (второй пересмотр). Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов». Анестезиология и реаниматология. 2019; 6: 5–19. https://doi.org/10.17116/anaesthesiology20190615; https://www.pharmacoeconomics.ru/jour/article/view/800

  9. 9
    Academic Journal

    Source: Medical science of Uzbekistan; No. 1 (2023): January-February; 09-13 ; Медицинская наука Узбекистана; № 1 (2023): январь-февраль; 09-13 ; O`zbekiston tibbiyot ilmi; No. 1 (2023): yanvar-fevral; 09-13 ; 2181-3612

    File Description: application/pdf

  10. 10
  11. 11
    Academic Journal

    Source: Mother and Baby in Kuzbass; № 3 (2022): сентябрь; 48-53 ; Мать и Дитя в Кузбассе; № 3 (2022): сентябрь; 48-53 ; 2542-0968 ; 1991-010X

    File Description: text/html; application/pdf

  12. 12
    Academic Journal

    Source: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 19, № 3 (2022); 15-24 ; Вестник анестезиологии и реаниматологии; Том 19, № 3 (2022); 15-24 ; 2541-8653 ; 2078-5658

    File Description: application/pdf

    Relation: https://www.vair-journal.com/jour/article/view/669/564; Ackermann M., Verleden S. E., Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19 // N. Engl. J. Med. ‒ 2020. – Vol. 383. – P. 120–128. doi:10.1056/NEJMoa2015432.; Allegra A., Innao V., Allegra A. G. et al. Coagulopathy and throm-boembolic events in patients with SARS-CoV-2 infection: Pathogenesis and management strategies // Ann. Hematol. – 2020. – Vol. 99. – P. 1953–1965. doi 10.1007/s00277-020-04182-4.; Armstrong R. A., Kane A. D., Cook T. M. Outcomes from intensive care in patients with COVID-19: A systematic review and meta-analysis of observational studies // Anaesth. – 2020. – Vol. 75. – P. 1340‒1349. doi. org/10.1111/anae.15201.; Bi X., Su Z., Yan H. et al. Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count // Platelets. – 2020. – P. 1–6. doi.org/10.1080/09537104.2020.1760230.; Chen G., Wu D., Guo W. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019 // J. Clin. Invest. – 2020. – Vol. 130. – P. 2620–2629. doi:10.1172/JCI137244.; Chen N., Zhou M., Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 322 novel coronavirus pneumonia in Wuhan, China: A descriptive study // Lancet. – 2020. – Vol. 395. – P. 507–323. doi:10.1016/S0140-6736(20)30211-7.; Colling M. E., Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms // Vasc. Med. – 2020. – Vol. 25. – P. 471–478. doi:10.1177/1358863X20932640.; D’Agnillo F., Walters K. A., Xiao Y. et al. Lung epithelial and endothelial damage, loss of tissue re-pair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19 // Sci. Transl. Med. – 2021. – Vol. 17, № 13. – P. 620. doi: doi:10.1126/scitranslmed.abj7790.; Dolhnikoff M., Duarte-Neto A. N., de Almeida Monteiro R. A. et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 // J. Thromb. Haemost. – 2020. – Vol. 18. № 6. – P. 1517–1519. doi:10.1111/jth.14844.; Elezkurtaj S., Greuel S., Ihlow J. et al. Causes of death and comorbidities in hospitalized patients with COVID-19 // Sci. Rep. – 2021. – Vol. 11, № 1. – P. 4263 doi.org/10.1038/s41598-021-82862-5.; Fox S. E., Akmatbekov A., Harbert J. L. et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans // Lancet Respir. Med. – 2020. – Vol. 8, № 7. – P. 681–686. doi:10.1016/S2213-2600(20)30243-5.; Getu S., Tiruneh T., Andualem H. et al. Coagulopathy in SARS-CoV-2 infected patients: Implication for the management of COVID-19 // J. Blood. Med. – 2021. – Vol. 12. – P. 635‒643. doi:10.2147/JBM.S304783.; Guan W. J., Ni Z. Y., Hu Y. et al. China medical treatment expert group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China // N. Engl. J. Med. – 2020. – Vol. 382, № 18. – P. 1708–1720 doi:10.1056/NEJMoa2002032.; Gu S. X., Tyagi T., Jain K. et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation // Nat. Rev. Cardiol. – 2021. – Vol. 18, № 3. – P. 194‒209. doi:10.1038/s41569-020-00469-1.; Helms J., Tacquard C., Severac F. et al. CRICS TRIGGERSEP Group (Clini-cal Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis) High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study // Int. Care Med. – 2020. – Vol. 46. – P. 1089–1098. Doi:10.1007/s00134-020-06062-x.; Iba T., Connors J. M., Levy J. H. The coagulopathy, endotheliopathy, and vasculitis of COVID-19 // Inflamm Res. – 2020. – Vol. 69, № 12. – P. 1181‒1189. doi:10.1007/s00011-020-01401-6.; Koriyama N., Moriuchi A., Higashi K. et al. COVID-19 with rapid progression to hypoxemia likely due to imbalance between ventilation and blood flow: A case re-port // Clin. Med. Insights Circ. Respir. Pulm. Med. – 2022. – Vol. 16. doi:10.1177/11795484211073273.; Leppkes M., Knopf J., Naschberger E. et al. Vascular occlusion by neu-trophil extracellular traps in COVID-19 // EBioMedicine. – 2020. – Vol. 58. – doi:10.1016/j.ebiom.2020.102925.; Levi M., Thachil J., Iba T. et al. Coagulation abnormalities and thrombosis in patients with COVID-19 // Lancet Haematol. – 2020. – Vol. 7, № 06. – P. e438–e440 doi:10.1016/S2352-3026(20)30145-9.; Lippi G., Plebani M., Henry B. M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis // Clin. Chimica Acta. – 2020. ‒ № 506. ‒ Р. 145‒148. doi:10.1016/j.cca.2020.03.022.; Mancini I., Baronciani L., Artoni A. et al. The ADAMTS13-von Willebrand factor axis in COVID-19 patients // J. Thromb. Haemost. – 2020. – Vol. 23. doi:10.1111/jth.15191.; McConnell M. J., Kawaguchi N., Kondo R. et al. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy // J. Hepatol. – 2021. – Vol. 75, № 3. – P. 647‒658. doi:10.1016/j.jhep.2021.04.050.; McGonagle D., O’Donnell J. S., Sharif K. et al. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia // Lancet Rheumatol. – 2020. – Vol. 2, № 7. – P. 437–445. Doi:10.1016/S2665-9913(20)30121-1.; Moore J. B., June C. H. Cytokine release syndrome in severe COVID19 // Sci. ‒ 2020. – Vol. 368. – P. 473–474 doi:10.1126/science.abb8925.; Page M. J., Pretorius E. A champion of host defense: a generic largescale cause for platelet dysfunction and depletion in infection. seminars in thrombosis and hemostasis // Thieme Med. Publishers. – 2020. – Vol. 46, № 3. – P. 302‒319. doi:10.1055/s-0040-1708827.; Ruggenenti P., Noris M., Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura // Kidney Int. – 2001. – Vol. 60, № 3. – P. 831–846. doi:10.1046/j.1523-1755.2001.060003831.; Scully M., How G. T. I treat thrombotic thrombocytopenic purpura and atyp-ical haemolytic uraemic syndrome // Br. J. Haematol. – 2014. – Vol. 164, № 6. – P. 759–766. doi:10.1111/bjh.12718.; Streetley J., Fonseca A.V., Turner J. et al. Stimulated release of intraluminal vesicles from Weibel-Palade bodies // Blood. – 2019. – Vol. 133, № 25. – P. 2707–2717. doi:10.1182/blood-2018-09-874552.; Ward S. E., Fogarty H., Karampini E. et al. Irish COVID-19 vasculopathy study (ICVS) investigators. ADAMTS13 regulation of VWF multimer distribution in severe COVID-19 // J. Thromb. Haemost. – 2021. – Vol. 19, № 8. – P. 1914-1921. doi:10.1111/jth.15409.; Wichmann D., Sperhake J. P., Lütgehetmann M. et al. Autopsy findings and venous thromboembolism in patients with COVID-19 // Ann. Intern. Med. – 2020. – Vol. 173, № 4. – P. 268-2776. doi:10.7326/M20-2003.; Wool G. D., Miller J. L. The Impact of COVID-19 Disease on platelets and coagulation // Pathobiology. – 2021. – Vol. 88, № 1. – P. 15‒27. doi:10.1159/00051200.; Yang M., Ng M. H., Li C. K. Thrombocytopenia in patients with severe acute respiratory syndrome // Hematology. – 2005. – Vol. 10, № 2. – P. 101–105. doi:10.1080/10245330400026170.; Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study // Lancet. – 2020. – Vol. 395. – P. 1054–1062. doi:10.1016/S0140-6736(20)30566-3.

  13. 13
    Academic Journal

    Source: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 19, № 1 (2022); 18-24 ; Вестник анестезиологии и реаниматологии; Том 19, № 1 (2022); 18-24 ; 2541-8653 ; 2078-5658

    File Description: application/pdf

    Relation: https://www.vair-journal.com/jour/article/view/622/535; Авдеев С. Н., Чучалин А. Г., Белевский А. С. Протокол лечения термическим гелиоксом (t-He/O2 ) больных c синдромом острой и обострением хронической дыхательной недостаточности. ‒ 2018. URL: https://spulmo. ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/; Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». 2021. URL: https://static0.minzdrav.gov.ru/system/attachments/ attaches/000/058/211/original/BMP-13.pdf [Дата обращения 28 ноября 2021 г.].; Зайцев А. А., Оковитый С. В. Кашель: дифференциальный диагноз и рациональная фармакотерапия // Терапевтический архив. – 2014. – Т. 86, № 12. – С. 85–91. doi:10.17116/terarkh2014861285-91.; Коронавирус в России. Статистика заражений коронавирусом в России на сегодня. URL: https://coronavirus-monitor.info/country/russia/ [Дата обращения 28 ноября 2021 г.].; Красновский А. Л., Григорьев С. П., Алехин А. И. и др. Применение подогреваемой кислородно-гелиевой смеси в комплексном лечении пациентов с внебольничной пневмонией // Клиническая медицина. – 2013. – Т. 91, № 5. – С. 38‒41. URL: https://cyberleninka.ru/article/n/primenenie-podog revaemoy-kislorodno-gelievoy-smesi-v-kompleksnom-lechenii-patsientovs-vnebolnichnoy-pnevmoniey [Дата обращения 26 октября 2021г.].; Петриков С. С., Журавель С. В., Шогенова Л. В. и др. Термическая гелий-кислородная смесь в лечебном алгоритме больных с COVID-19 // Вестник РАМН. – 2020. – Т. 75, № 5S. – С. 353–362. doi: https://doi.org/10.15690/vramn1412/; Смирнова М. И., Антипушина Д. Н., Драпкина О. М. Возможные варианты применения гелиево-кислородной смеси при острой респираторной патологии и в условиях пандемии COVID-19 // Профилактическая медицина. – 2020. – Т. 23, № 7. – С. 78–84. doi:10.17116/profmed20202307178.; Соколова О. П., Макарова А. В., Серезвин И. С. и др. Опыт применения гелиокса в лечении вирусной пневмонии при COVID-19 // Медицинский альянс. – 2021. – Т. 9, № 2. – С. 8–14. doi:10.36422/23076348-2021-9-2-8-14.; Atzrodt C., Maknojia I., McCarthy R. et al. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2 2020. doi:10.1111/febs.15375.; Berganza С., Zhang J. The role of helium gas in medicine // Med. Gas Res. – 2013. – Vol. 4, № 18. – P. 8. doi:10.1186/2045-9912-3-18.; Beurskens C. J., Aslami H., Beer F. M. et. al. Heliox allows for lower minute volume ventilation in an animal model of ventilator-induced lung injury // PLoS. One. – 2013. doi:10.1371/journal.pone.0078159.; Gluck E. H., Onorato D. J., Castriotta R. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis // Chest. – 1990. – Vol. 98, № 3. – P. 693-698. doi:10.1378/chest.98.3.693.; Hsu J. V., Stone R. V., Logan-Sinclair R. B. et al. Coughing freguency in patients with persistent cough; assessment using a 24 hour ambulatory recorder // Eur. Respir. J. – 1994. – Vol. 7. – P. 246–1253. doi:10.1183/09031936.94.07071246.; Kneyber M. C., Heerde M., Twisk J. W. et al. Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure // Crit. Care. – 2009. – Vol. 13, № 3. – R. 71. doi:10.1186/cc7880.; Shiue S. T., Gluck E. H. The use of helium-oxygen mixtures in the support of patients with status asthmaticus and respiratory acidosis // J. Asthma. – 1989. – Vol. 26, № 3. – P. 177–180. doi:10.3109/02770908909070987.; Szczapa T., Gadzinowski J. Use of heliox in the management of neonates with meconium aspiration syndrome // Neonatology. – 2011. – Vol. 100, № 3. – P. 265–270. doi:10.1159/000327531.; Watremez C., Liistro G., deKock M. et al. Effects of helium-oxygen on respiratory mechanics, gas exchange, and ventilation-perfusion relationships in a porcine model of stable methacholine-induced bronchospasm // Intens. Care Med. – 2003. – Vol. 29, № 9. – P. 1560–1566. doi:10.1007/s00134-003-1779-y

  14. 14
    Academic Journal

    Source: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 18, № 1 (2021); 47-56 ; Вестник анестезиологии и реаниматологии; Том 18, № 1 (2021); 47-56 ; 2541-8653 ; 2078-5658

    File Description: application/pdf

    Relation: https://www.vair-journal.com/jour/article/view/497/467; Авдеев С. Н. Неинвазивная вентиляция легких при новой коронавирусной инфекции COVID-19 // Пульмонология. – 2020. – Т. 30, № 5. – С. 679–687. DOI:10.18093/0869-0189-2020-30-5-679-687.; Временные методические рекомендации: «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». 2020. Ссылка активна на 01.10.2020 г. https://static0.rosminzdrav. ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_ COVID-19_v7.pdf; Ярошецкий А. И., Власенко А. В., Грицан А. И. и др. Применение неинвазивной вентиляции легких (второй пересмотр). Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов» // Анестезиология и реаниматология. – 2019. – Т. 6. – С. 5–19. DOI:10.17116/anaesthesiology20190615.; Ярошецкий А. И., Грицан А. И., Авдеев С. Н. и др. Диагностика и интенсивная терапия острого респираторного дистресс-синдрома // Анестезиология и реаниматология. – 2020. – Т. 2. – С. 5–39. DOI:10.17116/anaesthesiology20200215.; Alhazzani W., Morten H., Yaseen M. et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) // Crit. Care Med. – 2020. – Vol. 48, № 6. – P. 440–469. DOI:10.1097/CCM.0000000000004363.; Berton A., Prencipe N., Giordano R.•et al. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view // J. Endocrin. Invest. – 2020. DOI:10.1007/s40618-020-01325.; Cabrini L., Landoni G., Zangrillo A. Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure // Lancet. – 2020. – Vol. 395. – P. 685. DOI:10.1016/S0140-6736(20)30359-7.; Cheung J. C., Ho L. T., Cheng J. V. et al. Staff safety during emergency airway management for COVID-19 in Hong Kong // Lancet Respir. Med. – 2020. – Vol. 8, № 4. – P.19. DOI:10.1016/S2213-2600(20)30084-9.; Faculty of Intensive Care Medicine, Intensive Care Society, Association of Anaesthetists and Royal College of Anaesthetists. Critical care preparation and management in the COVID-19 pandemic. Available at: https://www.icmanaesthesiacovid- org/critical-care-preparation-and-manag ement- in-the-covid-19-pandemic (Accessed: Marсh 25, 2020).; Ferreyro B. L., Angriman F., Munshi L. et al. Association of noninvasive oxygenation strategies with all-cause mortalityin adults with acute hypoxemic respiratory failure. A systematic review and meta-analysis // JAMA. – 2020. – Vol. 324, № 1. – P. 57. DOI:10.1001/jama.2020.9524.; Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. – 2020. – Vol. 395. – P. 497–506. DOI:10.1016/S0140-6736(20)30183-5.; Kenneth E., John C., Philip A. et al. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients // Crit. Care. – 2020. – Vol. 24. – P.169. DOI:10.1186/s13054-020-02892-9.; Leung C. H., Joynt G. M., Gomersall C. D. et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: A randomized controlled crossover trial // J. Hosp. Infect. – 2019. – Vol. 101. – P. 84–87. DOI:10.1016 / j.jhin.2018.10.007.; Rochwerg B., Granton D., Wang D. X. et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: A systematic review and meta-analysis // Intens. Care Med. – 2019. – Vol. 45. – P. 563–572. DOI:10.1007/s00134-019-05590-5.; Sciascia S., Apra F., Baffa A. et al. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19 // Clin. Exp. Rheumatol. – 2020. – Vol. 38, № 3. – P. 529–532. www.ncbi.nlm.nih. gov/pubmed/32359035.; Wang K., Zhao W., Li J. et al. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China // Ann. Intens. Care. – 2020. – Vol. 10. – P.37 DOI:10.1186/s13613-020-00653-z.; Wang Y., Lu X., Chen H. et al. Clinical course and outcomes of 344 intensive care patients with COVID-19 // Am. J. Respir. Crit. Care Med. – 2020. – Vol. 201, № 11. – P. 1430–1434. DOI:10.1164 / rccm.202003-0736LE.; World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Based on data as of the 31 December 2003. https://www.who.int/csr/sars/country/table 2004_04_21/en (accessed 04/03/ 2020).; Xiaoling X., Tiantian L., Wei S. et al. Effective treatment of severe COVID-19 patients with tocilizumab // PNAS. – 2020. – Vol. 117, № 20. – P. 10970–10975. DOI:10.1073/pnas.2005615117.; Yang X., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study // Lancet Respir. Med. – 2020. – Vol. 8, № 5. – P. 475–481. DOI:10.1016/S2213-2600(20)30079-5.; Yin W., Weiwei J., Qi H. at al. Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China. DOI:10.1101/2020.03.06.200 32342.

  15. 15
  16. 16
  17. 17
  18. 18
    Academic Journal

    Source: Transplantologiya. The Russian Journal of Transplantation; Том 12, № 3 (2020); 220-230 ; Трансплантология; Том 12, № 3 (2020); 220-230 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2020-12-3

    File Description: application/pdf

    Relation: https://www.jtransplantologiya.ru/jour/article/view/517/575; https://www.jtransplantologiya.ru/jour/article/view/517/585; Evseev AK, Zhuravel SV, Alentiev AYu, Goroncharovskaya IV, Petrikov SS. Membranes in extracorporeal blood oxygenation technology. Membranes and Membrane Technologies. 2019;1(4):201– 2 1 1 . https://doi.org/10.1134/S2517751619040024; Hill JD, O'Brien TG, Murray JJ, Dontigny L, Bramson ML, Osborn JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med. 1972;286(12):629–634. PMID: 5060491 https://doi.org/10.1056/NEJM197203232861204; Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective study. JAMA. 1979;242(20):2193–2196. PMID: 490805 https://doi.org/10.1001/jama.242.20.2193; Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888–1895. PMID: 19822628 https://doi.org/10.1001/jama.2009.1535; Noah MA, Peek GJ, Finney SJ, Griffiths MJ, Harrison DA, Grieve R, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA. 2011;306(15):1659– 1668. PMID: 21976615 https://doi.org/10.1001/jama.2011.1471; Журавель С.В., Косолапов Д.А., Кецкало М.В. Организация программы экстракорпоральной мембранной оксигенации у взрослых пациентов в многопрофильном стационаре. Опыт Регенсбурга (Германия). Трансплантология. 2014;(4):28–32. Zhuravel SV, Kosolapov DA, Ketskalo MV. The organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients in a multidisciplinary hospital. Review of experience in Regensburg (Germany). Transplantologiya. The Russian Journal of Transplantation. 2014;(4):28–32. (In Russ.).; Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965– 1975. PMID: 29791822 https://doi.org/10.1056/NEJMoa1800385; Курилова О.А., Журавель С.В., Романов А.А., Маринин П.Н., Цурова Д.Х., Каллагов Т.Э. и др. Опыт применения экстракорпоральной мембранной оксигенации для обеспечения двусторонней трансплантации легких. Вестник трансплантологии и искусственных органов. 2014;(2):66–74. Kurilova OA, Zhuravel SV, Romanov AA, Marinin PN, Tsurova DKh, Kallagov TE, et al. Experience with application of extracorporeal membrane oxygenation in double lung transplantation. Russian Journal of Transplantology and Artificial Organs. 2014;(2):66–74. (In Russ.). https://doi.org/10.15825/1995-1191-2014-2-66-74; Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351– 1363. PMID: 19762075 https://doi.org/10.1016/S0140-6736(09)61069-2; Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(2):163– 172. PMID: 30642776 https://doi.org/10.1016/S2213-2600(18)30452-1; Бахарев С.А., Попугаев К.А., Киселев К.В., Самойлов А.С., Удалов Ю.Д., Жангазинов А.Л. и др. Механизмы развития геморрагических осложнений при проведении экстракорпоральной мембранной оксигенации. Пилотное исследование. Анестезиология и реаниматология. 2020;(1):25–34. Bakharev SA, Popugaev KA, Kiselev KV, Samoylov AS, Udalov YuD, Zhangazinov AL, et al. Mechanisms of hemorrhagic complications during extracorporeal membrane oxygenation. A pilot study. Russian Journal of Anаеsthesiology and Reanimatology = Anesteziologiya i reanimatologiya. 2020;(1):25–34. (In Russ.). https://doi.org/10.17116/anaesthesiology202001125; Schmidt M, Zogheib E, Rozé H, Repesse X, Lebreton G, Luyt CE. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med. 2013;39(10):1704–1713. PMID: 23907497 https://doi.org/10.1007/s00134-013-3037-2; Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, Rycus PT, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory extracorporeal membrane oxygenation survival prediction (RESP) Score. Am J Respir Crit Care Med. 2014;189(11):1374–1382. PMID: 24693864 https://doi.org/10.1164/rccm.201311-2023OC; ELSO Guidelines for cardiopulmonary extracorporeal life support extracorporeal life support organization, Version 1.4 August 2017 Ann Arbor, MI, USA. Available at: https://www.elso.org/Portals/0/ELSO%20Guidelines%20General%20All%20ECLS%20Version%201_4.pdf [Accessed March 23, 2019]; Sladen RN. ECMO in the adult patient, core critical care. Anesthesia Analgesia. 2018;126(2):713. https://doi.org/10.1213/ANE.0000000000002675; Sangalli F, Patroniti N, Pesenti A. (eds.) ECMO-Extracorporeal life support in adults. Switzerland AG: Springer; 2014.; Extracorporeal Membrane Oxygenation (ECMO): Initiation and management– adult – in patient: clinical practice guideline. USA: University of Wisconsin Hospitals and Clinics Authority; 2018.; Papazian L, Aubron C, Brochard L, Chiche JD, Combes A, Dreyfuss D, et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care. 2019;9(1):69. PMID: 31197492 https://doi.org/10.1186/s13613-019-0540-9; Villar J, Blanco J, del Campo R, Andaluz-Ojeda D, Díaz-Domínguez FJ, Muriel A, et al. Assessment of PaO2/FiO2 for stratification of patients with moderate and severe acute respiratory distress syndrome. BMJ Open. 2015;5(3):e006812. PMID: 25818272 https://doi.org/10.1136/ bmjopen-2014-006812; Villar J, Ambrós A, Soler JA, Martínez D, Ferrando C, Solano R, et al. Age, Pao2/Fio2, and plateau pressure score: a proposal for a simple outcome score in patients with the acute respiratory distress syndrome. Crit Care Med. 2016;44(7):1361–1369. PMID: 27035239 https://doi.org/10.1097/CCM.0000000000001653; Heiss KF, Bartlett RH. Extracorporeal membrane oxygenation: an experimental protocol becomes a clinical service. Adv Pediatr. 1989;36:117–136. PMID: 2675567; Dechert RE, Park PK, Bartlett RH. Evaluation of the oxygenation index in adult respiratory failure. J Trauma Acute Care Surg. 2014;76(2):469–473. PMID: 24458052 https://doi.org/10.1097/TA.0b013e3182ab0d27; Chen WL, Lin WT, Kung SC, Lai CC, Chao CM. The value of oxygenation saturation index in predicting the outcomes of patients with acute respiratory distress syndrome. J Clin Med. 2018;7(8). pii: E205. PMID: 30096809 https://doi.org/10.3390/jcm7080205; Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720–723. PMID: 3202424 https://doi.org/10.1164/ajrccm/138.3.720; Kangelaris KN, Calfee CS, May AK, Zhuo H, Matthay MA, Ware LB. Is there still a role for the lung injury score in the era of the Berlin definition ARDS? Ann Intensive Care. 2014;4(1):4. PMID: 24533450 https://doi.org/10.1186/2110-5820-4-4; DesPrez K, McNeil JB, Wang C, Bastarache JA, Shaver CM, Ware LB, Oxygenation saturation index predicts clinical outcomes in ARDS. Chest. 2017;152(6):1151–1158. PMID: 28823812 https://doi.org/10.1016/j.chest.2017.08.002; Schmidt M, Pham T, Arcadipane A, Agerstrand C, Ohshimo S, Pellegrino V, et al. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome: an international multicenter prospective cohort. Am J Respir Crit Care Med. 2019;200(8):1002–1012. PMID: 31144997 https://doi.org/10.1164/rccm.201806-1094OC; Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis. 1988;137(5):1159–1164. PMID: 3057957 https://doi.org/10.1164/ajrccm/137.5.1159; Gattinoni L, Pesenti A. The concept of “baby lung”. Intensive Care Med. 2005;31(6):776–784. PMID: 15812622 https://doi.org/10.1007/s00134-005-2627-z; Fan E, Del Sorbo L, Goligher EC, Hodgson CL, Munshi L, Walkey AJ, et al. An Official American thoracic society/ European society of intensive care medicine/Society of critical care medicine. Clinical practice guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195(9):1253– 1263. PMID: 28459336 https://doi.org/10.1164/rccm.201703-0548ST; Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747–755. PMID: 25693014 https://doi.org/10.1056/NEJMsa1410639; Kim HS, Kim JH, Chung CR, Hong SB, Cho WH, Cho YJ, et al. Lung compliance and outcomes in patients with acute respiratory distress syndrome receiving ECMO. Ann Thorac Surg. 2019;108(1):176–183. PMID: 30836100 https://doi.org/10.1016/j.athoracsur.2019.01.055; Rozé H, Doassans G, Repusseau B, Ouattara A. Decrease of thoracopulmonary compliance with pressure assist controlled ventilation in ARDS patients under ECMO and transported to a referral centre. Intensive Care Med. 2017;43(1):148–149. PMID: 27815586 https://doi.org/10.1007/s00134-016-4616-9; Walkey AJ, Goligher EC, Del Sorbo L, Hodgson CL, Adhikari NKJ, Wunsch H, et al. Low tidal volume versus non-volume-limited strategies for patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(Suppl 4):S271–S279. PMID: 28846440 https://doi.org/10.1513/AnnalsATS.201704-337OT; Ichikado K, Suga M, Muranaka H, Gushima Y, Miyakawa H, Tsubamoto M, et al. Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology. 2006;238(1):321–329. PMID: 16293804 https://doi.org/10.1148/radiol.2373041515; Chung JH, Kradin RL, Greene RE, Shepard JA, Digumarthy SR. CT predictors of mortality in pathology confirmed ARDS. Eur Radiol. 2011;21(4):730– 737. PMID: 20927526 https://doi.org/10.1007/s00330-010-1979-0; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. The ARDS definition task force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533. PMID: 22797452 https://doi.org/10.1001/jama.2012.5669; Ruyang Z, Zhaoxi W, Yongyue W, Paula TA, Zhaozhong Z, Li S, et al. A two-stage association study identifies a high risk window of acute respiratory distress syndrome onset time correlated with poor 28 day overall survival. A53. Respiratory failure: risk factors and outcomes in ARDS. American Thoracic Society – 2016, (California, San-Francisco, 13–18 may 2016). San-Francisco, 2016. Abstr A7794.; Zhang R, Wang Z, Tejera P, Frank AJ, Wei Y, Su L, et al. Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study. Intensive Care Med. 2017;43(3):399–407. PMID: 28032130 https://doi.org/10.1007/s00134-016-4638-3; Iwashyna TJ. Trajectories of recovery and dysfunction after acute illness, with implications for clinical trial design. Am J Respir Crit Care Med. 2012;186(4):302– 304. PMID: 22896591 https://doi.org/10.1164/rccm.201206-1138ED; Rozencwajg S, Pilcher D, Combes A, Schmidt M. Outcomes and survival prediction models for severe adult acute respiratory distress syndrome treated with extracorporeal membrane oxygenation. Crit Care. 2016;20(1):392 PMID: 27919283 https://doi.org/10.1186/s13054-016-1568-y; Nesseler N, Launey Y, Isslame S, Flécher E, Lebouvier T, Mallédant Y, et al. Is extracorporeal membrane oxygenation for severe acute respiratory distress syndrome related to intra-abdominal sepsis beneficial? Intensive Care Med. 2015;41(5):943–945. PMID: 25800583 https://doi.org/10.1007/s00134-015-3743-z; Takauji S, Hayakawa M, Ono K, Makise H. Respiratory extracorporeal membrane oxygenation for severe sepsis and septic shock in adults: a propensity score analysis in a multicenter retrospective observational study. Acute Med Surg. 2017;4(4):408–417. PMID: 29123901 https://doi.org/10.1002/ams2.296; Roch A, Hraiech S, Masson E, Grisoli D, Forel JM, Boucekine M, et al. Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center. Intensive. Intensive Care Med. 2014;40(1):74-83. PMID: 24170143 https://doi.org/10.1007/s00134-013-3135-1; https://www.jtransplantologiya.ru/jour/article/view/517

  19. 19
    Academic Journal

    Source: Tuberculosis and Lung Diseases; Том 98, № 9 (2020); 6-12 ; Туберкулез и болезни легких; Том 98, № 9 (2020); 6-12 ; 2542-1506 ; 2075-1230

    File Description: application/pdf

    Relation: https://www.tibl-journal.com/jour/article/view/1456/1458; Алексеев А. М., Шупинский О. В., Храпов К. Н. Интенсивная терапия больных с тяжелым течением гриппа А(H1N1), осложненного пневмонией // Вестник анестезиологии и реаниматологии. ‒ 2009. ‒ № 6. – С. 35-38.; Алексеев А. М., Яковлев А. А., Швечкова М. В., Сейлиев А. А., Волчков В. А., Розенберг О. А. Сурфактант-терапия пневмонии и ОРДС, ассоциированных с вирусом A/H1N1 // Забайкальский медицинский журнал. ‒ 2011. ‒ № 1. ‒ С. 23-27.; Баутин А. Е., Осовских В. В., Хубулава Г. Г., Гранов Д. А., Козлов И. А., Ерохин В. В., Лихванцев В. В., Царенко С. В., Казеннов В. В., Жилин Ю. Н., Попцов В. Н., Шульга А. Э., Кириллов Ю. А., Сейлиев А. А., Волчков В. А., Розенберг О. А. Многоцентровые клинические испытания сурфактанта-BL для лечения респираторного дистресс-синдрома взрослых // Клинические исследования лекарственных средств в России. ‒ 2002. ‒ № 2. ‒ С. 18-23.; Розенберг О. А., Данилов Л. Н., Волчков В. А., Лебедева Е. С., Дубровская В. Ф., Валькович А. А., Клестова О. В., Кириллов Ю. А., Сейлиев А. А., Шалджян А. А., Лошакова Л. В., Шульга А. Э., Жуйков А. Г. Фармакологические свойства и терапевтическая активность отечественных препаратов легочного сурфактанта // Бюлл. эксперим. биол. и мед. ‒ 1998. ‒ Т. 126, № 10. ‒ С. 455-458.; Bautin A., Chubulava G., Kozlov I., Poptzov V., Osovskikh V., Seiliev A., Volchkov V. and Rosenberg O. Surfactant therapy for patients with ards after cardiac surgery // J. Liposome Research. ‒ 2006. ‒ Т. 16, № 3. ‒ С. 265-272.; Busani S., Girardis M., Biagioni E. Surfactant therapy and intravenous Zanamivir in severe respiratory failure due to persistent influenza A/H1N1 2009 virus infection // Am. J. Respir. Critical Care Med. ‒ 2010. ‒ Vol. 182, № 10. ‒ Р. 1334.; Fukushi M. , Tohru M., Miyoshi-Akiyama, Kubo S., Yamamoto K., Kudo K. Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 virus // PLoS ONE. ‒ 2012. ‒ Vol. 7, № 8. ‒ Р. e42419. doi:10.1371/journal.pone.0042419.; Günther A., Siebert C., Schmidt R., Ziegler S., Grimminger F., Yabut M., Temmesfeld B., Walmrath D., Morr H., Seeger W. Surfactant alterations in severe pneumonia, ARDS and cardiogenic lung edema // Am. J. Resp. Crit. Care Med. ‒ 1996. ‒ Vol. 153, № 1. ‒ Р. 176-184. http://dx.doi.org/10.1164/ajrccm.153.1.8542113. PMID: 12030716.; Kula R., Maca J., Sklienka P., Szturz P., Jahoda S., Czerny D., Chulek V., Sukenik P. Exogenous surfactant as a component of complex non-ECMO therapy for ARDS caused by influenza A virus (2009 А1/Н1) // Bratisl Lek Listy. – 2011. ‒ № 112. ‒ Р. 218-222.; Numata M., Kandasamy P., Nagashima Y., Posey J., Hartshorn K., Woodland D., Voelker D. R. Phosphatidylglycerol suppresses influenza A virus infection // Am. J. Respir. Cell. Mol. Biol. ‒ 2012. ‒ Vol. 46, № 4. ‒ Р. 479-487. doi:10.1165/rcmb.2011-0194OC.; Rosenberg O. A., Bautin A. E., Osovskich V. V., Tsibulkin E. K., Gavrilin S. V., Kozlov I, A. When to start surfactant therapy (ST-thetrapy) of acute lung injury? // Eur. Respir. J. ‒ 2001. ‒ Vol. 18, Suppl. 38. ‒ P. 153, 7s. (11th ERS Annual Congress, Berlin).; Rosenberg O. A., Bautin A. E., Seiliev A. A. Late Start of surfactant therapy and surfactant drug composition as major causes of failure of phase III multi-center clinical trials of surfactant therapy in adults with ARDS // Intern. J. Biomedicine. ‒ 2018. ‒ № 8. ‒ Р. 253-254.; Rosenberg O., Seiliev A., Zhuikov A., Lung surfactants: Correlation between biophysical characteristics, composition and therapeutic efficacy. In: Gregory Gregoriadis, ed., Liposome Technology, Informa Healthcare, Taylor&Francis Group, 2006, 3rd ed, Vol. III, Ch. 17. ‒ Р. 317-346.; Takano H. Pulmonary surfactant itself must be a strong defender against SARS-CoV-2 // Medical Hypotheses. ‒ 2020. № 144: 110020. ‒ Р. 1-2.; van Iwaarden F. J., van Golde L. M. J. Pulmonary surfactant and lung defense. In: Robertson B., Taeusch H.W. (eds.). Surfactant therapy for lung disease // Lung Biol. Health Dis. ‒ Vol. 84. New York: Marcel Dekker Inc; 1995. ‒ Р. 75-84.; Vlasenko A., Osovskikh V., Tarasenko M., Rozenberg O. Efficiency of surfactant therapy for ALI/ARDS in homogenous nosologic groups of patients // Eur. Respir. J. ‒ 2005. ‒ Vol. 26, Suppl. 49. ‒ P. 90.; Witczak A., Prystupa A., Kurys-Denis E. Acute respiratory distress syndrome (ARDS) complicating influenza A/H1N1v infection – a clinical approach // Ann. Agricultural Environmental Med. ‒ 2013. ‒ Vol. 20, № 4. ‒ Р. 820-822.

  20. 20